Blood-Based Prognostic Biomarkers in Neuroendocrine Tumour: A Retrospective Study
#1311
Introduction: Markers of systemic inflammation –such as the neutrophil:lymphocyte ratio (NLR), platelet:lymphocyte ratio (PLR) and lymphocyte:monocyte ratio (LMR) - have been shown to correlate with poor prognosis in multiple solid organ tumours. Analysis of CLARINET showed no significant association between NLR and progression-free survival.
Aim(s): To investigate the prognostic value of NLR, PLR and LMR in patients with metastatic NET.
Materials and methods: We identified patients with histologically diagnosed NET, who had a full blood count in the 7 days prior to biopsy or resection. The prognostic impact of NLR – NLR>5 vs NLR3 vs NLRmedian vs PLRmedian vs LMR
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Diakos C, Chan D, Gurney E, Bailey D, Barnes T,
To read the full abstract, please log into your ENETS Member account.